mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
-0.042 |
0.8 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.0081 |
0.8 |